Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Star AF II Study

NCT01203748 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01203748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01203748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Star AF II Study
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2010
Completion date
January 31, 2014
Enrollment
589 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation